Osteoarthritis: FDA reporting patterns
41,919 FDA FAERS reports mention Osteoarthritis. 37,265 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 10,529 reports
- Etanercept: 6,180 reports
- Methotrexate: 5,397 reports
- Alendronate: 5,106 reports
- Rituximab: 3,641 reports
- Leflunomide: 3,521 reports
- Abatacept: 3,420 reports
- Tocilizumab: 3,324 reports
- Tofacitinib: 3,075 reports
- Hydroxychloroquine: 3,022 reports
- Infliximab: 2,986 reports
- Diclofenac: 2,855 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.